FDA Should Undo Incentives For Single-Use Products, Device Reprocessing Expert Says

Medtech Insight sat down with Dan Vukelich, president and CEO of the Association of Medical Device Reprocessors, to discuss the need for sustainable alternatives to limit waste from medical devices.

• Source: Shutterstock

A majority of Dan Vukelich’s time is used educating manufacturers on the regulatory incentives against reprocessing devices.

“Single-use labeling isn't decided by FDA, it's up to the manufacturer,” the president and CEO of the Association of Medical...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from ESG

Pharma Deutschland Seeks To Enter Urban Wastewater Legal Dispute

The Urban Wastewater Treatment Directive “in its current form, is at an end,” insists Pharma Deutschland CEO Jörg Wieczorek. To put the directive to bed once and for all, the association has applied for leave to intervene in the ongoing EU legal battle in its own right.

Over The Counter: How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke

HBW Insight speaks to Bayer Consumer Health's global strategy director for regulatory, medical, safety, quality, and compliance Emese Csoke about how least how widening access to self-care solutions can be balanced with equity with regards to affordability.

Opella Claims Sustainability Leadership Position With Global B Corp Certification

 
• By 

Cutting greenhouse gas emissions and obtaining its electricity from renewable sources has helped Opella earn global B Corp certification.

German Associations Call For EU Green Claims Directive Trilogue Suspension

 
• By 

Pharma Deutschland is one of 21 German associations calling for trilogue negotiations in relation to the EU Green Claims Directive to be suspended while a “comprehensive and independent written impact assessment” is undertaken.

More from HBW Insight

Kris Joshi Named Norstella CEO, Prioritizes AI Innovation

 
• By 

Joshi joins the parent company of Citeline, home of HBW Insight, to focus on AI, business harmonization and long-term growth.

HHS Wants Employees (And Public?) To Report Diversity, Equity And Inclusion Discrimination

 
• By 

A survey asks FDA staff to disclose whether DEI policies caused discrimination or resulted in disciplinary action against career employees over the past five years, but uses a web form that the general public also can access.

Haleon Invests In State-Of-The-Art Oral Care R&D Facility In The UK

 
• By 

Haleon described the opening of a new oral care R&D facility in the UK as a “major investment reflecting our commitment to advancing science and innovation.”